Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.01.2023 | Case report

Multiple drugs

Thrombocytopenia, peripheral neuropathy and no response: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Yin J, et al. Bortezomib, et al. promising alternative for patients with refractory or relapsed thrombotic thrombocytopenic purpura after rituximab treatment. British Journal of Haematology 199: 619-622, No. 4, Nov 2022. Available from: URL: http://doi.org/10.1111/bjh.18430 Yin J, et al. Bortezomib, et al. promising alternative for patients with refractory or relapsed thrombotic thrombocytopenic purpura after rituximab treatment. British Journal of Haematology 199: 619-622, No. 4, Nov 2022. Available from: URL: http://​doi.​org/​10.​1111/​bjh.​18430
Metadaten
Titel
Multiple drugs
Thrombocytopenia, peripheral neuropathy and no response: 3 case reports
Publikationsdatum
01.01.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-31111-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Insulin

Case report

Multiple drugs

Case report

Covid-19-vaccine

Case report

Clozapine